'Survival curves' diaporamas de présentation

Objectives

The Radiobiology Behind Dose Fractionation Bill McBride Dept. Radiation Oncology David Geffen School Medicine UCLA, Los Angeles, Ca. wmcbride@mednet.ucla.edu. Objectives. To understand the mathematical bases behind survival curves Know the linear quadratic model formulation

1.01k views • 83 slides

Advanced Statistics for Interventional Cardiologists

Advanced Statistics for Interventional Cardiologists. What you will learn. Introduction Basics of multivariable statistical modeling Advanced linear regression methods Logistic regression and generalized linear model Multifactor analysis of variance Cox proportional hazards analysis

1.26k views • 65 slides

Cell and Tissue Survival Assays

Cell and Tissue Survival Assays. Lecture 6. In vitro clonogenic assays Calculation of plating efficiency and surviving fraction In vivo clonogenic assays Bone marrow stem cell assays, jejunal crypt stem cell assay, skin clones, kidney tubules Functional endpoints.

1.37k views • 50 slides

Follicular Lymphoma

Follicular Lymphoma. Michael Bassetti PhD July 26th, 2007 Clinical Rotation Talk. Overview of Presentation. Follicular Lymphoma Epidemiology Diagnosis Grade/Stage Treatments Future Directions radioimmunotherapy. Lymphomas.

1.94k views • 40 slides

Some survival basics

Some survival basics. Developments from the Kaplan-Meier method October 29 2007. Kaplan-Meier Method. Nonparametric Estimation from Incomplete Observations E. L. Kaplan, Paul Meier Journal of the American Statistical Association , Vol. 53, No. 282 (Jun., 1958), pp. 457-481.

565 views • 37 slides

Chapter 11 Survival Analysis Part 1

686 views • 37 slides

Matthew Lamb ICAP-NY mrl2013@columbia

Use of Patient-Level HIV Care and Treatment Reports for Focused Site Support, Evidence-Based Decision Making, and More!. Matthew Lamb ICAP-NY mrl2013@columbia.edu. Outline. Brief overview: where the data comes from and how the feedback reports are generated

456 views • 34 slides

Improving Quality of Trials through the MRC Network of Hubs for Trials Methodology Research

Improving Quality of Trials through the MRC Network of Hubs for Trials Methodology Research. Professor Lucinda (Cindy) Billingham Professor of Biostatistics Director, MRC Midland Hub for Trials Methodology Research Biostatistics Lead, Cancer Research UK Clinical Trials Unit

551 views • 33 slides

Cancer associated chronic illness - a new cancer story

Cancer associated chronic illness - a new cancer story . Jane Maher NHS Improvement Lead (cancer) CMO Macmillan cancer Support Chair NCSI Consequences of treatment work stream . Cancer in the UK in 2008. 300,000 new cases of cancer in UK in 2008 1

538 views • 28 slides

Lecture 3

Lecture 3. Survival analysis. Problem. Do patients survive longer after treatment A than after treatment B? Possible solutions: ANOVA on mean survival time? ANOVA on median survival time?. Progressively censored observations . Current life table Completed dataset Cohort life table

411 views • 28 slides

What is Survival Analysis?

INTRODUCTION TO SURVIVAL ANALYSIS M. H. Rahbar, PhD Professor of Biostatistics Department of Epidemiology Director, Data Coordinating Center College of Human Medicine Michigan State University. What is Survival Analysis?.

1.13k views • 25 slides

Mortality of Centenarians: A Study Based on the Social Security Administration Death Master File

Mortality of Centenarians: A Study Based on the Social Security Administration Death Master File. Leonid A. Gavrilov, Ph.D. Natalia S. Gavrilova, Ph.D. Center on Aging NORC and University of Chicago Chicago, Illinois, USA. What Do We Know About Mortality of Centenarians?.

358 views • 24 slides

Prognosis

Prognosis. FMED 1531 Lecture 11 Spring 2007 Kim Cooper, Ph.D. Lecture Outline. What is a prognosis? How are prognoses determined? How is prognosis reported? What is a prognostic factor? Example: breast cancer How can we compare survival curves?. What is a prognosis?.

845 views • 24 slides

Improvement and Deterioration in Physical Functioning among Israelis Aged 60 and over

Myers-JDC-Brookdale Institute. Center for Research on Aging. Improvement and Deterioration in Physical Functioning among Israelis Aged 60 and over. Jenny Brodsky, Tal Spalter , Yitschak Shnoor October 17, 2012. Outline. Background Study Purpose and Hypothesis Method of Analysis

335 views • 22 slides

What Have We Learned From The UK TAVI Registry?

What Have We Learned From The UK TAVI Registry?. Simon Ray UHSM Manchester Academic Health Sciences Centre. NO CONFLICT OF INTEREST TO DECLARE. UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry. Development Collaborative program

440 views • 19 slides

Economic evaluation of outcomes: long term primary and surrogate endpoints

Economic evaluation of outcomes: long term primary and surrogate endpoints. Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, 26-28 June 2008. Measuring health and disease. Many measures are used to assess health outcomes, ranging from:

295 views • 15 slides

Economic evaluation of outcomes: long term primary and surrogate endpoints

Economic evaluation of outcomes: long term primary and surrogate endpoints. Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, 26-28 June 2008. Measuring health and disease. Many measures are used to assess health outcomes, ranging from:

284 views • 15 slides

Supporter Attrition within Regular Giving at PDSA

Supporter Attrition within Regular Giving at PDSA. Victoria Barham Senior Marketing Analyst barham.victoria@pdsa.org.uk. Regular Giving at PDSA. Multiple Regular Giving Products Traditional Regular Giving, Cashcascade and Sponsorship All with different Supporter Profiles

232 views • 8 slides

Supplemental Data

Supplemental Data. Lyndsay Harris corresponding author. Figure X Associations of IGF-IR signatures in combination with IGF1 mRNA and outcome.

148 views • 4 slides

Figure 6 . Survival curves of aluminum ultralight rigid wheelchairs (AURWs), titanium ultralight rigid wheelchairs (TURWs), and aluminum ultralight folding wheelchairs (AUFWs).

130 views • 1 slides